CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakayama, M.
Right arrow Articles by Namiki, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakayama, M.
Right arrow Articles by Namiki, A.
Canadian Journal of Anesthesia 48:234-237 (2001)
© Canadian Anesthesiologists' Society, 2001

General Anesthesia

Perioperative intravenous flurbiprofen reduces postoperative pain after abdominal hysterectomy

Masayasu Nakayama, MD*, Hiromichi Ichinose, MD*, Shuji Yamamoto, MD*, Ken-ichi Nakabayashi, MD*, Osamu Satoh, MD* and Akiyoshi Namiki, MD PhD{dagger}

* From the Division of Anesthesia,
{dagger} Obihiro Kosei Hospital, Obihiro, and Sapporo Medical University School of Medicine, Sapporo, Japan.

Address correspondence to: Dr. M. Nakayama, Division of Anesthesia, Obihiro Kosei Hospital, West-6, South-8-1, Obihiro 080-0016, Japan. Phone: +0155/24-4161; Fax: +0155/25-7851; E-mail: miyabi{at}zc4.so-net.ne.jp


    Abstract
 TOP
 Abstract
 Material and methods
 Results
 Discussion
 References
 
Purpose: To assess whether perioperative intravenous administration of flurbiprofen, a non-steroidal anti-inflammatory drug, reduced postoperative pain after abdominal hysterectomy.

Methods: Forty-five patients undergoing abdominal hysterectomy were randomly assigned to one of three groups of equal size. A control group (CONT) received a placebo 30 min before and at the end of surgery. The other two groups, PRE and POST, received 1 mg•kg–1 flurbiprofen iv 30 min before and at the end of surgery, respectively. All patients received identical general and epidural anesthesia. Postoperatively, 50 mg diclofenac pr was given for pain relief on patient demand. One of the authors assessed pain using a 10 cm visual analog scale at rest and during coughing at the first request for diclofenac, and at 15, 24, 48, and 72 hr after surgery. The number of times diclofenac was required during the first 24 hr after surgery was also recorded.

Results: The number of diclofenac requests in the PRE (1.8 ± 0.4) and POST groups (2.0 ± 0.4) were less than in the CONT group (3.0 ± 0.4). The PRE group showed lower visual analog scale at rest at 15 and 24 hr and on coughing at 24, 48, and 72 hr after surgery than the CONT and POST groups.

Conclusion: Intravenous 1 mg•kg–1 flurbiprofen administered during anesthesia reduces postoperative rescue analgesic requirement after abdominal hysterectomy. Moreover, flurbiprofen is more effective when given before than after surgery.

NON-STEROIDAL anti-inflammatory drugs (NSAIDs) provide postoperative pain relief after different types of surgery.1,2 Flurbiprofen, an injectable NSAID, is an effective and safe analgesic when the parenteral route is required.3,4

Pre-emptive analgesia decreases the growth of pain when antinociceptive treatment is given before noxious stimulation because it prevents the establishment of central sensitization.5 The preemptive efficacy of NSAIDs is controversial: not all studies have reported benefit.58 We investigated whether flurbiprofen iv, given in a preemptive manner, reduce postoperative pain after abdominal hysterectomy .


    Material and methods
 TOP
 Abstract
 Material and methods
 Results
 Discussion
 References
 
After institutional approval and informed consent, we studied 45 ASA physical status I women, 40 to 60-yr-old, undergoing elective abdominal hysterectomy (vertical lower abdominal incision) because of myoma of the uterus. Patients who suffered from chronic pain were excluded from the study. Before surgery, each patient was instructed in the evaluation of pain using the visual analog scores using a ruler (VAS; 0 cm = no pain to 10 cm = the worst possible pain).

Patients were premedicated with 3-4 mg midazolam im 30 min before arrival in the operating room. They received at least 500 ml acetated Ringer's solution before anesthesia. The ECG and hemoglobin oxygen saturation were monitored continuously, and arterial pressure was measured automatically by an oscillographic method every five minutes. An epidural catheter was placed through an 18-Gauge Tuohy needle using the loss of resistance technique at the T11–12 interspace, and tested with 2 ml lidocaine 1.5% with 1:200,000 epinephrine followed by 10 ml of the same lidocaine solution. General anesthesia was induced with 3 mg•kg–1 thiamylal iv, and tracheal intubation was facilitated with 0.1 mg•kg–1 vecuronium iv. Anesthesia was maintained with sevoflurane1% to 2%, nitrous oxide 67% in oxygen, and with epidural block using lidocaine1.5%. At the time of wound closure, 5 ml bupivacaine 0.25% were administered through the epidural catheter. The catheter was removed in the operating room. Narcotics were not used either parenterally or epidurally during the study period.

Patients were randomly assigned, via sealed envelope assignment, to one of three groups of equal size. The CONT group received Intralipid® as placebo 30 min before and at the end of surgery. The PRE group received 1 mg•kg–1 flurbiprofen iv 30 min before surgery and a placebo at the end of surgery. The POST group received a placebo 30 min before surgery and flurbiprofen at the end of surgery. The placebo and flurbiprofen were mixed with 100 ml saline and given over 15 min. This test solution was prepared by one anesthesiologist, and another anesthesiologist who was blinded to the solution performed anesthesia. Both placebo and the flurbiprofen solution looked the same.

For postoperative pain relief, diclofenac suppository was administered in increments of 50 mg on patient demand. One of the authors (MN), who was blinded to group allocation, evaluated the intensity of postoperatively pain using VAS at the first rescue analgesics request, and at 15, 24, 48, and 72 hr after the surgery at rest and on coughing. The time to first request and the number of times diclofenac was used in the first 24 hr after the surgery were recorded. If the patients experienced sever nausea and vomiting, this was treated with 10 mg metoclopramide iv and noted. Side effects associated with flurbiprofen were recorded, if present.

All data are presented as mean ± SD. Demographic data (age, height, weight, and duration of surgery) and the time to the first request for diclofenac were analyzed using one-way analysis of variance, followed by Fisher's protected least significant difference test. VAS and the number of requests for diclofenac among groups were analyzed by Kruskal-Wallis test. Incidence of adverse events was compared by chi-squared analysis. P values < 0.05 were considered statistically significant.


    Results
 TOP
 Abstract
 Material and methods
 Results
 Discussion
 References
 
The three groups were comparable in pre- and intraoperative characteristics (TableGo). The time to first diclofenac request in the POST group was longer than in the CONT and PRE groups. The number of diclofenac requests during the first 24 hr after surgery was less in the PRE and POST groups than in the CONT group. Compared with the CONT and POST groups, the PRE group showed lower VAS scores at rest at 15 and 24 hr postoperatively and on coughing at 24, 48, and 72 hr postoperatively (FigureGo). The incidence of postoperative nausea and vomiting were not different among the groups (TableGo). No patients showed any adverse effects associated with flurbiprofen.


View this table:
[in this window]
[in a new window]
 
TABLE Demographic and Perioperative Data
 


View larger version (19K):
[in this window]
[in a new window]
 
FIGURE VAS scores for postoperative pain (Mean ± SD).

Compared with the CONT and POST groups, the PRE group showed lower VAS scores at rest at 15 and 24 hr postoperatively and on coughing at 24, 48, and 72 hr postoperatively. *P < 0.05 vs PRE.

F; Time of first diclofenac request.

 

    Discussion
 TOP
 Abstract
 Material and methods
 Results
 Discussion
 References
 
Diclofenac requirement after abdominal hysterectomy was less in both flurbiprofen groups than in the control group. Moreover, preoperative administration of flurbiprofen showed lower postoperative VAS scores than postoperative administration, which indicated a preemptive analgesic effect with flurbiprofen.

The efficacy of preemptive analgesic treatment with NSAIDs remains disputed. Elhaki and Nafie6 showed that intravenous tenoxicam before induction of anesthesia reduced postoperative opioid consumption after Cesarean section. A recent report by Rømsing et al.7 also demonstrated that, for tonsillectomy, preoperative intravenous ketorolac reduced the postoperative use of fentanyl more than postoperative administration. In contrast, Buggy et al.8 showed that administration of diclofenac im prior to laparoscopic tubal ligation produced no additional benefit compared with postoperation administration. In our study, preoperative administration of flurbiprofen reduced postoperative pain more than postoperative administration during the 72 hr period monitored, not only at rest, but also on coughing.

The inflammatory reaction in tissue damaged during surgery could provide a source of postoperative sensory signals and induce central sensitization. An injectable form of flurbiprofen has been made available by emulsifying lipid microspheres which have a high affinity to inflamed tissues.3 Swift et al.9 found that preoperative administration of flurbiprofen reduced the increase in tissue levels of immunoreactive bradykinin. Thus, we speculated that injectable flurbiprofen is a suitable NSAID to induce a preemptive effect.

The onset of the analgesic action of intravenous flurbiprofen occurs within 30 min of its administration, and lasts 5-12 hr.3 Because we administered flurbiprofen 30 min before beginning surgery in the PRE group, its effects should have lasted throughout the operation in this group of patients. The dose of flurbiprofen was chosen on the basis of current recommendations.3,4

There was no reduction in the incidence of postoperative nausea and vomiting in the patients treated with flurbiprofen, although NSAIDs have been reported to produce antiemetic effects postoperatively.10 Mikawa et al.3 also demonstrated that preoperative flurbiprofen is effective for postoperative pain relief but not for the prevention of emesis after pediatric strabismus surgery.

The NSAIDs are associated with an increase in bleeding time due to antiplatelet effects. However, with our single dose infusion of flurbiprofen, intraoperative blood losses in the flurbiprofen-treated and placebo groups were similar, and no adverse effect on postoperative bleeding was seen in any of the patients. These results are in agreement with other studies which found no significant increase in bleeding associated with NSAID administration.1,2,6

We conclude that the intravenous administration of flurbiprofen during anesthesia is effective in reducing postoperative rescue analgesic requirement. Moreover, preoperative flurbiprofen will diminish postoperative pain in a preemptive manner.

Accepted for publication November 18, 2000.


    References
 TOP
 Abstract
 Material and methods
 Results
 Discussion
 References
 
1 Perttunen K, Nilsson E, Kalso E. I.v. diclofenac and ketorolac for pain after thoracoscopic surgery. Br J Anaesth 1999; 82: 221–7.[Abstract/Free Full Text]

2 Tarkkila P, Saarnivaara L. Ketoprofen, diclofenac or ketorolac for pain after tonsillectomy in adults? Br J Anaesth 1999; 82: 56–60.[Abstract/Free Full Text]

3 Mikawa K, Nishina K, Maekawa N, Shiga M, Obara H. Dose-response of flurbiprofen on postoperative pain and emesis after paediatric strabismus surgery. Can J Anaesth 1997; 44: 95–8.[Abstract/Free Full Text]

4 Tanaka S, Sonoda H, Nakabayashi K, Namiki A. Preoperative flurbiprofen provides pain relief after laparoscopic cholecystectomy. (Japanese) Masui 1997; 46: 679–83.[Medline]

5 Woolf CJ, Chong M-S. Preemptive analgesia – treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993; 77: 362–79.[Medline]

6 Elhakim M, Nafie M. I.v. tenoxicam for analgesia during Caesarean section. Br J Anaesth 1995; 74: 643–6.[Abstract/Free Full Text]

7 Rømsing J, Østergaard D, Walther-Larsen S, Valentin N. Analgesic efficacy and safety of preoperative versus postoperative ketorolac in paediatirc tonsillectomy. Acta Anaesthesiol Scand 1998; 42: 770–5.[Medline]

8 Buggy DJ, Wall C, Carton EG. Preoperative or postoperative diclofenac for laparoscopic tubal ligation. Br J Anaesth 1994; 73: 767–70.[Abstract/Free Full Text]

9 Swift JQ, Garry MG, Roszkowski MT, Hargreaves KM. Effect of flurbiprofen on tissue levels of immunoreactive bradykinin and acute postoperative pain. J Oral Maxillofac Surg 1993; 51: 112–6.[Medline]

10 Kokki H, Homan E, Tuovinen K, Purhonen S. Peroperative treatment with i.v. ketoprofen reduces pain and vomiting in children after strabismus surgery. Acta Anaesthesiol Scand 1999; 43: 13–8.[Medline]




This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
Y. Xu, Z. Tan, J. Chen, F. Lou, and W. Chen
Intravenous flurbiprofen axetil accelerates restoration of bowel function after colorectal surgery: [Le flurbiprofene axetil intraveineux accelere la restauration de la fonction intestinale apres une chirurgie colorectale]
Can J Anesth, July 1, 2008; 55(7): 414 - 422.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. U. Adachi, H. Sano, M. Doi, and S. Sato
Preemptive Analgesia by Nonsteroidal Antiinflammatory Drugs
Anesth. Analg., November 1, 2006; 103(5): 1331 - 1332.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. Yoshitani, M. Kawaguchi, K. Tatsumi, N. Sasaoka, N. Kurumatani, and H. Furuya
Intravenous Administration of Flurbiprofen Does Not Affect Cerebral Blood Flow Velocity and Cerebral Oxygenation Under Isoflurane and Propofol Anesthesia
Anesth. Analg., February 1, 2004; 98(2): 471 - 476.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakayama, M.
Right arrow Articles by Namiki, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakayama, M.
Right arrow Articles by Namiki, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS